Ophthalmology Innovation Source

Exciting things are happening in ophthalmology! Pykus Therapeutics has expanded their patent portfolio for PYK-2101, a first-in-class retinal sealant technology designed to accelerate visual recovery, enhance surgical outcomes, and dramatically improve the post-operative experience for patients with retinal detachment. https://lnkd.in/gs5NuKVu #PykusTherapeutics #Ophthalmology #Innovation

2025 marks our 15th year, and one of our greatest joys has been witnessing companies grow from inception to this! Please join us in congratulating Oculis and Riad SHERIF - a respected member of the innovation community - on a banner start to 2025! We look forward to keeping up with the next 10 months, Team Oculis!

Exciting news from Pykus Therapeutics as they prepare to present initial clinical data on PYK-2101, a novel retinal sealant, at the 𝗩𝗮𝗶𝗹 𝗩𝗶𝘁𝗿𝗲𝗰𝘁𝗼𝗺𝘆 𝟮𝟬𝟮𝟱 meeting! Innovation in retinal surgery continues to advance, and we’re thrilled to see groundbreaking solutions like this shaping the future of ophthalmology. https://lnkd.in/e2PgxTk6 #Ophthalmology #PykusTherapeutics #Innovation #RetinalSurgery

In this episode of Eye on Innovation Podcast, host Carey Powers launches the Next-Gen Innovators series with Dr. Vikram Shankar, Stanford ophthalmologist and co-founder of Drop Mate, Inc., to explore how this groundbreaking device is transforming clinical disinfection—saving time, reducing waste, and setting a new standard in eye care. Tune in now! https://lnkd.in/ducKC6ZF #OIS #OISPodcast #Ophthalmology #Innovation #CareyPowers #VikramShankar #DropMate

The The Collaborative Community on Ophthalmic Innovation is hosting its 5th International Meeting, a virtual conference on 𝗝𝗮𝗻𝘂𝗮𝗿𝘆 𝟮𝟯-𝟮𝟰, 𝟮𝟬𝟮𝟱, titled "𝙉𝙚𝙬 𝙁𝙧𝙤𝙣𝙩𝙞𝙚𝙧𝙨 𝙞𝙣 𝙊𝙥𝙝𝙩𝙝𝙖𝙡𝙢𝙞𝙘 𝘼𝙄 𝙖𝙣𝙙 𝙄𝙣𝙣𝙤𝙫𝙖𝙩𝙞𝙤𝙣." This two-day event will gather global experts from academia, government, patient groups, and industry to dive into the latest advancements in AI and cutting-edge technologies transforming eye care. Explore the program and revisit past events here: www.cc-oi.org Don’t miss out on this exciting opportunity to engage with thought leaders shaping the future of ophthalmology! #Ophthalmology #Innovation #AI #EyeCare #CCOI2025

Oculis announces positive Phase 2 results for OCS-05 in the ACUITY trial, marking a significant milestone in treating acute optic neuritis.  Read the full release for details: https://lnkd.in/g845gfGe #Oculis #OpticNeuritis #ClinicalTrials #InnovationInEyeCare

In this week's OIS Podcast episode, we’re diving into 𝗧𝗵𝗲 𝗣𝗼𝘄𝗲𝗿 𝗼𝗳 𝗖𝗼𝗹𝗹𝗮𝗯𝗼𝗿𝗮𝘁𝗶𝗼𝗻: 𝗙𝗿𝗼𝗺 𝗘𝗮𝗿𝗹𝘆-𝗦𝘁𝗮𝗴𝗲 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 𝘁𝗼 𝗖𝗼𝗺𝗺𝗲𝗿𝗰𝗶𝗮𝗹 𝗦𝘁𝗿𝗮𝘁𝗲𝗴𝘆! 𝗘𝘆𝗲 𝗼𝗻 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 host Carey Powers brings you a special double-feature episode featuring: Dr. Fran Lasowski of 20/20 OptimEyes Technologies and Dr. Wendy Naimark of Ripple Therapeutics sharing how strategic partnerships accelerate breakthroughs and tackle challenges in biotech development. Tracy Valorie, biotech veteran, offering expert insights on why commercial strategy needs to begin day one, covering market access, reimbursement, and manufacturing readiness. Tune in now! https://lnkd.in/gCybsYrA #OIS #OISPodcast #Ophthalmology #Innovation #CareyPowers #FranLasowski #WendyNaimark #TracyValorie

Wishing you safe, peaceful and the happiest of holidays! 

In the latest episode of the OIS Podcast – The Rob and Jai Show, recorded live at OIS XIV, hosts Rob Rothman, MD and Jai G. Parekh, MD, MBA, FAAO sit down with Eric Schlumpf, President & CEO of Stuart Therapeutics, to discuss the company’s groundbreaking work in ophthalmic innovation. Tune in to learn how Stuart Therapeutics is leveraging clinical trial breakthroughs and strategic partnerships to address major unmet needs in ophthalmology. 𝗟𝗶𝘀𝘁𝗲𝗻 𝗻𝗼𝘄! https://lnkd.in/g36DyzJ2 #OIS #OISPodcast #Ophthalmology #Innovation #RobRothman #JaiParekh #EricSchlumpf #StuartTherapuetics

At last month’s OIS XIV in San Diego, Onsite Insights host Bindu Manne caught up with David RP Almeida MD MBA PhD, one of the most sought-after clinical investigators in retina and a trailblazer in advancing clinical trial efficiency. Dr. Almeida shared his expertise on the transformative potential of decentralized clinical trials, offering startups a pathway to faster, cost-effective development and more. Don’t miss this fascinating conversation on the future of clinical trials and accelerating innovation in ophthalmology. Watch now! 🔗 https://lnkd.in/dB9TFxCC     #OISXIV #OnsiteInsights #ClinicalTrials #OphthalmologyInnovation #Startups